Authors: O.V. Kuriata1, O.Yu. Sirenko1, T.K. Lysunets2, A.S. Lehkobyt2, A.S. Vorotylyshcheva2
1State Institution “Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine”, Dnipro, Ukraine
2Municipal Institution “І.І. Mechnikov Regional Clinical Hospital”, Dnipro, Ukraine
Abstract
The article deals with the issues of treatment for chronic diseases of the musculoskeletal system during the period of exacerbation. Attention was paid to the choice of a drug from the group of non-steroidal anti-inflammatory agents and a drug with metabolic action. Data are presented on the studies of the efficacy and safety of the combined administration of meloxicam (Loxidol) and Cocarnit.
Key words: musculoskeletal system; osteoarthritis; synovitis; seronegative arthropathy; rheumatoid arthritis; treatment